Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
B
Barrick Mining
B
|
+$169M |
| 2 |
AMRZ
Amrize Ltd
AMRZ
|
+$69.6M |
| 3 |
NBIS
Nebius Group N.V.
NBIS
|
+$60M |
| 4 |
Q
Qnity Electronics Inc
Q
|
+$48.7M |
| 5 |
CRWV
CoreWeave
CRWV
|
+$47.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$697M |
| 2 |
Apple
AAPL
|
+$641M |
| 3 |
Microsoft
MSFT
|
+$503M |
| 4 |
Amazon
AMZN
|
+$284M |
| 5 |
Tesla
TSLA
|
+$271M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.64% |
| 2 | Consumer Discretionary | 11.52% |
| 3 | Communication Services | 11.09% |
| 4 | Healthcare | 10.44% |
| 5 | Industrials | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
Oric Pharmaceuticals
ORIC
$1.43B
| $705K | ﹤0.01% |
86,200
+20,100
| +30% | +$231K |
|
2252
Savers
SVV
$1.65B
| $702K | ﹤0.01% |
75,200
| – | – |
|
|
NAGE
2253
Niagen Bioscience
NAGE
$242M
| $700K | ﹤0.01% |
110,100
+3,200
| +3% | +$22.3K |
|
|
ABX
2254
Abacus Global Management
ABX
$834M
| $692K | ﹤0.01% |
80,900
+6,900
| +9% | +$45.4K |
|
2255
Ibotta
IBTA
$722M
| $680K | ﹤0.01% |
29,900
+2,900
| +11% | +$78.3K |
|
|
RC
2256
Ready Capital
RC
$289M
| $679K | ﹤0.01% |
311,656
| – | – |
|
2257
Gogo Inc
GOGO
$383M
| $676K | ﹤0.01% |
145,100
+4,000
| +3% | +$29.3K |
|
2258
Kura Sushi USA
KRUS
$637M
| $675K | ﹤0.01% |
12,900
| – | – |
|
2259
Donegal Group Class A
DGICA
$692M
| $669K | ﹤0.01% |
33,500
+1,900
| +6% | +$37.3K |
|
2260
Covenant Logistics
CVLG
$865M
| $661K | ﹤0.01% |
30,000
-1,400
| -4% | -$29.3K |
|
2261
Similarweb
SMWB
$770M
| $655K | ﹤0.01% |
87,474
| – | – |
|
2262
Polestar Automotive Holding UK
PSNY
$1.99B
| $643K | ﹤0.01% |
30,093
+3,323
| +12% | +$69.4K |
|
2263
Compass Diversified
CODI
$908M
| $641K | ﹤0.01% |
133,600
+4,300
| +3% | +$27.2K |
|
2264
HBT Financial
HBT
$1.33B
| $631K | ﹤0.01% |
24,400
| – | – |
|
2265
Greif Class B
GEF.B
$4.24B
| $627K | ﹤0.01% |
8,400
| – | – |
|
2266
Standard BioTools
LAB
$312M
| $627K | ﹤0.01% |
489,660
+19,000
| +4% | +$25.5K |
|
|
SHCO
2267
DELISTED
Soho House & Co
SHCO
| $616K | ﹤0.01% |
68,800
+13,100
| +24% | +$116K |
|
2268
Bumble
BMBL
$344M
| $611K | ﹤0.01% |
171,200
| – | – |
|
2269
Cullinan Oncology
CGEM
$1.26B
| $603K | ﹤0.01% |
58,300
+8,000
| +16% | +$72.2K |
|
2270
Prime Medicine
PRME
$580M
| $590K | ﹤0.01% |
+170,100
| New | +$757K |
|
2271
Anavex Life Sciences
AVXL
$316M
| $585K | ﹤0.01% |
164,400
| – | – |
|
|
SHOE
2272
Shoe Station Group
SHOE
$420M
| $581K | ﹤0.01% |
34,400
| – | – |
|
2273
Riley Exploration Permian
REPX
$796M
| $573K | ﹤0.01% |
21,700
+2,600
| +14% | +$69.1K |
|
2274
Latham Group
SWIM
$921M
| $573K | ﹤0.01% |
90,200
| – | – |
|
|
DCBO
2275
Docebo
DCBO
$561M
| $568K | ﹤0.01% |
25,525
-2,900
| -10% | -$69.3K |
|
Similar funds
Swiss National Bank's Q4 2025 Portfolio in Review
As of Q4 2025, Swiss National Bank held 2,386 positions worth $168B, down 2.5% from $172B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Swiss National Bank withdrew a net $7.75B in Q4 2025, closing 75 positions and reducing 690 holdings. Its most notable exit was Kellanova, an estimated $76.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, Swiss National Bank opened a new position in Barrick Mining worth $197M.
- Swiss National Bank's largest Q4 2025 buy was Barrick Mining: 4,513,129 shares worth $197M.
- Swiss National Bank added most to Insmed in Q4 2025, an estimated $37.9M increase.
- Swiss National Bank's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $697M.
- Swiss National Bank fully exited Kellanova in Q4 2025, selling an estimated $76.6M.
- Swiss National Bank's ten largest holdings make up 37% of its $168B portfolio in Q4 2025.
- Swiss National Bank opened 71 new positions and closed 75 in Q4 2025.
- Swiss National Bank's portfolio value fell 2.5% quarter-over-quarter to $168B.
Based on Swiss National Bank's 13F filing for Q4 2025, filed 12 Feb 2026.